- Home
- OGN vs DEI Comparison
OGN vs DEI Comparison
Compare OGN & DEI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OGN
- DEI
- Stock Information
- Founded
- OGN 1923
- DEI 1971
- Country
- OGN United States
- DEI United States
- Employees
- OGN N/A
- DEI N/A
- Industry
- OGN Biotechnology: Pharmaceutical Preparations
- DEI Real Estate Investment Trusts
- Sector
- OGN Health Care
- DEI Real Estate
- Exchange
- OGN Nasdaq
- DEI Nasdaq
- Market Cap
- OGN 2.5B
- DEI 2.5B
- IPO Year
- OGN N/A
- DEI 2006
- Fundamental
- Price
- OGN $9.59
- DEI $15.91
- Analyst Decision
- OGN Hold
- DEI Buy
- Analyst Count
- OGN 4
- DEI 9
- Target Price
- OGN $18.00
- DEI $17.88
- AVG Volume (30 Days)
- OGN 3.5M
- DEI 1.6M
- Earning Date
- OGN 08-05-2025
- DEI 08-05-2025
- Dividend Yield
- OGN 0.84%
- DEI 4.77%
- EPS Growth
- OGN N/A
- DEI N/A
- EPS
- OGN 2.88
- DEI 0.32
- Revenue
- OGN $6,294,000,000.00
- DEI $995,663,000.00
- Revenue This Year
- OGN N/A
- DEI $1.41
- Revenue Next Year
- OGN $1.11
- DEI $2.29
- P/E Ratio
- OGN $3.33
- DEI $50.34
- Revenue Growth
- OGN N/A
- DEI 1.93
- 52 Week Low
- OGN $8.01
- DEI $12.39
- 52 Week High
- OGN $23.10
- DEI $20.50
- Technical
- Relative Strength Index (RSI)
- OGN 46.81
- DEI 67.17
- Support Level
- OGN $9.74
- DEI $15.21
- Resistance Level
- OGN $10.27
- DEI $16.25
- Average True Range (ATR)
- OGN 0.36
- DEI 0.42
- MACD
- OGN -0.02
- DEI 0.08
- Stochastic Oscillator
- OGN 20.22
- DEI 94.74
About OGN Organon & Co.
Organon & Co is a science-based pharmaceutical company that develops and delivers health solutions through a portfolio of prescription therapies within women's health, biosimilars, and established brands. The Company's operations include the following product portfolio: Women's health, Biosimilars and Established medicines. Geographically, it derives a majority of its revenue from Europe and Canada followed by the United States and then Asia Pacific and Japan. The company generates the majority of its revenue from the Established Brands product portfolio.
About DEI Douglas Emmett Inc.
Douglas Emmett Inc is an integrated, self-administered, and self-managed REIT. It is an owner and operator of office and multifamily properties located in coastal submarkets in Los Angeles and Honolulu. The group focuses on owning, acquiring, developing, and managing a substantial market share of office properties and multifamily communities in neighborhoods with supply constraints, high-end executive housing, and key lifestyle amenities. Its properties are located in the Beverly Hills, Brentwood, Burbank, Century City, Olympic Corridor, Santa Monica, Sherman Oaks/Encino, Warner Center/Woodland Hills and Westwood submarkets of Los Angeles County, California, and in Honolulu, Hawaii. It has two business segments, the office segment and the multifamily segment.